Target
D(3) dopamine receptor
Ligand
BDBM50207160
Substrate
n/a
Meas. Tech.
ChEMBL_1630050 (CHEMBL3872756)
Ki
0.140000±n/a nM
Citation
 Chen, XWSun, YYFu, LLi, JQ Synthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics. Eur J Med Chem 123:332-353 (2016) [PubMed]  Article 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM50207160
Synonyms:
CHEMBL3962525
Type:
Small organic molecule
Emp. Form.:
C23H34N4OS
Mol. Mass.:
414.607
SMILES:
CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:6.5,wD:9.9,(10.69,-26.4,;12.22,-26.5,;13.05,-25.22,;14.59,-25.27,;15.3,-26.65,;15.35,-23.94,;16.9,-23.94,;17.67,-22.61,;19.21,-22.61,;19.98,-23.94,;21.52,-23.94,;22.28,-22.61,;23.82,-22.61,;24.6,-23.94,;26.14,-23.94,;26.9,-22.61,;26.14,-21.27,;24.6,-21.27,;28.44,-22.61,;29.37,-23.89,;30.81,-23.37,;30.81,-21.83,;31.93,-20.81,;31.62,-19.32,;30.19,-18.85,;29.01,-19.88,;29.37,-21.37,;19.21,-25.27,;17.67,-25.27,)|
Structure:
Search PDB for entries with ligand similarity: